Q2 2022

Source filing unavailable

Q2 2022 · —

Revenue—

Net Income

-$203.29M

N/M vs Q2 2021

EPS Diluted

-$5.16

no prior Q2 2021 on file

Operating Income-$197,110,000—

Operating Cash Flowderived-$67,886,000—

Free Cash Flowderived

Same quarter

Metric	Q2 2022	Q2 2021
Net Income	-$203.29M	-$45.42M
EPS Diluted	-$5.16	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biohaven Ltd. · CIK 1935979 · Engraved from SEC EDGAR